Institute of Clinical and Molecular Virology

Milk Transmission of Viruses: Prevention of mother to child transmission of Human T-cell leukemia Virus Type 1 (HTLV-1) (Milk-TV) Nov. 1, 2020 - Oct. 31, 2029 Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (B9) (GRK 2504 TP B9) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504) April 1, 2024 - Sept. 30, 2028 GRK 2504: Enhancing immunogenicity of Human T-cell leukaemia virus Type 1 (HTLV-1) by interfering with viral transcription (A2) (GRK 2504 A2) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504) Jan. 1, 2019 - Sept. 30, 2028 Computer-based antiviral drug development: targeting CDKs/vCDKs as crucial determinants of cytomegalovirus and Epstein-Barr virus infections (GRK 2504 A1) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504) Jan. 1, 2019 - Sept. 30, 2028 Analyse de l'interaction entre HTLV-1 et le récepteur GLUT1 par une approche de biologie structurale (VI_SIM_ANRS_HTLV-1 GLUT1) June 1, 2025 - May 31, 2027 P189: Generation of recombinant vaccine candidates against BoDV-1 Jan. 1, 2026 - Dec. 31, 2026 HMOs and HTLV-1 (VI-BaCaTec_HMOs and HTLV-1) Jan. 1, 2025 - June 30, 2026 P165-OA: Lipid nanoparticles for targeted delivery of HIV-1 antigens and genetic immunomodulators Jan. 1, 2025 - June 30, 2026 A094: Host cell factors and nonstructural proteins of SARS-CoV-2 July 1, 2023 - June 30, 2026 P147: Modelling the intestinal barrier to analyse HTLV-1 transmission Nov. 1, 2024 - April 30, 2026